GLYCANS INC. Trademark

Trademark Overview

On Sunday, October 17, 2021, a trademark application was filed for GLYCANS INC. with the United States Patent and Trademark Office. The USPTO has given the GLYCANS INC. trademark a serial number of 97078373. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, October 4, 2023. This trademark is owned by Cognitive Clarity Inc.. The GLYCANS INC. trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations acting on the central nervous system
glycans inc.

General Information

Serial Number97078373
Word MarkGLYCANS INC.
Filing DateSunday, October 17, 2021
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateWednesday, October 4, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations acting on the central nervous system
Disclaimer with Predetermined Text"INC."

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, November 4, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCognitive Clarity Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressEdmonds, WA 98026

Trademark Events

Event DateEvent Description
Wednesday, October 4, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Wednesday, October 4, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Wednesday, October 4, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, June 20, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, June 20, 2023NON-FINAL ACTION E-MAILED
Tuesday, June 20, 2023NON-FINAL ACTION WRITTEN
Thursday, April 27, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 26, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 26, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, March 31, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, March 31, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 31, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, October 26, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, October 26, 2022NON-FINAL ACTION E-MAILED
Wednesday, October 26, 2022NON-FINAL ACTION WRITTEN
Monday, July 25, 2022EXAMINER'S AMENDMENT ENTERED
Monday, July 25, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, July 25, 2022EXAMINERS AMENDMENT E-MAILED
Monday, July 25, 2022EXAMINERS AMENDMENT -WRITTEN
Friday, July 22, 2022ASSIGNED TO EXAMINER
Thursday, November 4, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, October 20, 2021NEW APPLICATION ENTERED

Related Keywords

glycans nervous system central acting preparations pharmaceutical